[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].

IF 0.3 Q4 UROLOGY & NEPHROLOGY
Nephrologie Pub Date : 2004-01-01
S Canet, V Garrigue, J Bismuth, G Chong, A Lesnik, P Taourel, G Mourad
{"title":"[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].","authors":"S Canet,&nbsp;V Garrigue,&nbsp;J Bismuth,&nbsp;G Chong,&nbsp;A Lesnik,&nbsp;P Taourel,&nbsp;G Mourad","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In our series of 1374 renal transplantations performed between February 1970 and December 2002, we observed 6 cases of infection due to Nocardia asteroides. There were 4 males and 2 females, aged 49.8 +/- 12 years (29 to 63 years). One patient received his first transplantation and the 5 others retransplants. Three patients had PRA > 80%, one 28% and one 40%. One patient was diabetic and two had HCV infection. Two of 6 patients experienced acute rejection episodes. Nocardiosis localisation was pulmonary in 5 cases, cerebral in two and mediastinal in one. All patients recovered after reduction of immunosuppression and appropriate antibiotherapy with trimethoprim-sulfamethoxasole (TMP-SMX). When we analyzed the role of immunosuppression, we observed that only two cases were observed in the 933 recipients transplanted between 1985 and 2002 and receiving cyclosporin, contrasting with 4 cases among 174 recipients transplanted between 1996 and 2002 and receiving tacrolimus. Our data suggest that high immunologic risk patients, heavy immunosuppression, and perhaps tacrolimus-based immunosuppression are risk factors of nocardial infection. Early diagnosis of this severe infection, reduction of immunosuppression and appropriate therapy with TMP-SMX resulted in complete recovery in all our patients.</p>","PeriodicalId":18929,"journal":{"name":"Nephrologie","volume":"25 2","pages":"43-8"},"PeriodicalIF":0.3000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In our series of 1374 renal transplantations performed between February 1970 and December 2002, we observed 6 cases of infection due to Nocardia asteroides. There were 4 males and 2 females, aged 49.8 +/- 12 years (29 to 63 years). One patient received his first transplantation and the 5 others retransplants. Three patients had PRA > 80%, one 28% and one 40%. One patient was diabetic and two had HCV infection. Two of 6 patients experienced acute rejection episodes. Nocardiosis localisation was pulmonary in 5 cases, cerebral in two and mediastinal in one. All patients recovered after reduction of immunosuppression and appropriate antibiotherapy with trimethoprim-sulfamethoxasole (TMP-SMX). When we analyzed the role of immunosuppression, we observed that only two cases were observed in the 933 recipients transplanted between 1985 and 2002 and receiving cyclosporin, contrasting with 4 cases among 174 recipients transplanted between 1996 and 2002 and receiving tacrolimus. Our data suggest that high immunologic risk patients, heavy immunosuppression, and perhaps tacrolimus-based immunosuppression are risk factors of nocardial infection. Early diagnosis of this severe infection, reduction of immunosuppression and appropriate therapy with TMP-SMX resulted in complete recovery in all our patients.

[诺卡菌病——在肾移植中引入新的免疫抑制剂后是否经常观察到?]。
在1970年2月至2002年12月间进行的1374例肾移植手术中,我们观察到6例由诺卡菌引起的感染。男性4例,女性2例,年龄49.8±12岁(29 ~ 63岁)。1例患者接受了第一次移植,其他5例患者接受了再次移植。PRA > 80% 3例,28% 1例,40% 1例。1例糖尿病患者,2例丙型肝炎病毒感染。6例患者中有2例出现急性排斥反应。诺卡菌病定位肺5例,脑2例,纵隔1例。所有患者在减轻免疫抑制和适当的甲氧苄啶-磺胺甲氧沙唑(TMP-SMX)抗生素治疗后均恢复。当我们分析免疫抑制的作用时,我们观察到在1985年至2002年期间接受环孢素移植的933例受者中只有2例,而在1996年至2002年期间接受他克莫司移植的174例受者中有4例。我们的数据表明,高免疫风险患者,严重的免疫抑制,也许他克莫司为基础的免疫抑制是无心感染的危险因素。这种严重感染的早期诊断,减少免疫抑制和适当的TMP-SMX治疗导致所有患者完全康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信